Century Therapeutics to Present at Global Investment Conference

Century Therapeutics

PHILADELPHIA, PACentury Therapeutics, Inc. (NASDAQ: IPSC) announced that CEO Brent Pfeiffenberger, Pharm.D., will deliver a company presentation at the H.C. Wainwright 27th Annual Global Investment Conference. The event takes place September 9-10, 2025, in New York, NY, where members of Century’s management team will also meet with investors.

An on-demand webcast of the presentation will be available beginning September 5, 2025, and remain accessible on the company’s website for at least 30 days.

Century Therapeutics is a clinical-stage biotechnology company specializing in developing iPSC-derived cell therapies for autoimmune diseases and cancers. Leveraging advances in cellular reprogramming, genetic engineering, and manufacturing, the company aims to create off-the-shelf therapies designed to improve patient access and outcomes.

READ:  Verrica Pharmaceuticals to Present Phase 2 Data on VP-315 at Major Immunotherapy Conference

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.